The Effect of Schizonepeta tenuifolia on Osteoblast

형개(荊芥)가 조골세포(造骨細胞)에 미치는 영향(影響)

  • Lee, Joo-Yup (Department of preventive medicine, College of Oriental Medicine, Kyungwon University) ;
  • Hwang, Gwi-Seo (Department of preventive medicine, College of Oriental Medicine, Kyungwon University)
  • 이주엽 (경원대학교 한의학과 예방의학교실) ;
  • 황귀서 (경원대학교 한의학과 예방의학교실)
  • Received : 2009.11.30
  • Accepted : 2009.12.13
  • Published : 2009.12.31

Abstract

Objectives : The author aimed to evaluate the effect of BuOH fraction(ST) from Schizonepeta tenuifolia on osteoblast proliferation in murine calvarial cells. Methods : The osteoblast separated from murine calvariae was cultivated for 10 days and evaluated the cell function. After the addition of ST on the culture medium, we determined the effect of ST on the cell proliferation, protein synthesis, alkaline phosphatase activity, collagen synthesis, and apoptosis of the osteoblast. Results : 1. ST increased the proliferation of osteoblast, and restored the decreased cell number in glucocorticoid (GC)-treated osteoblast. 2. ST increased protein synthesis of osteoblast, and restored the decreased protein synthesis in GC-treated osteoblast. 3. ST increased ALP activity of osteoblast, and restored the decreased enzyme activity in GC-treated osteoblast. 4. ST increased collagen synthesis of osteoblast, and restored the decreased collagen synthesis in GC-treated osteoblast. 5. ST did not change the survival rate of osteoblast, but increased the survival rate in GC-treated osteoblast. Conclusions : It is concluded that ST might reduce the osteoporosis resulted from augumentation of osteoblast proliferation.

Keywords

References

  1. 대한병리학회. 병리학 PATHOLOGY, 고문사, p1001-1008, 2000.
  2. Weinstein RS, Jilka RL, Parfitt AM, Manolagas. Inhibition of osteoblastogenesis and promotion of apoptosis pf osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone, J. Clin. Invest 101 : 274-282, 1998.
  3. Wildemann B, Burkhardt N, Luebberstedt M, Vordemvenne T, Schmidmaier G. Proliferating and differentiating effects of three different growth factors on pluripotent mesenchymal cells and osteoblast like cells. J Orthop Surg Res. 20 ; 27, 2007
  4. Koch H, Jadlowiec JA, Campbell PG. Insulin-like growth factor-I induces early osteoblast gene expression in human mesenchymal stem cells. Stem Cells Dev. 14 : 621-31, 2005. https://doi.org/10.1089/scd.2005.14.621
  5. Kim HK, Cho SG, Kim JH, Doan TK, Hu QS, Ulhaq R, Song EK, Yoon TR. Mevinolin enhances osteogenic genes(ALP, type I collagen and osteocalcin), CD44, CD47 and CD51 expression during osteogenic differentiation. Life Sci. 27 ; 84(9-10) : 290-5, 2009. https://doi.org/10.1016/j.lfs.2008.12.017
  6. Sowa H, Kaji H, Yamaguchi T, Sugimoto T, Chihara K. Activations of ERK1/2 and JNK by transforming growth factor beta negatively regulate Smad3-induced alkaline phosphatase activity and mineralization in mouse osteoblastic cells. J. Biol Chem. 277(39) : 36024-31, 2002. https://doi.org/10.1074/jbc.M206030200
  7. 牛耕, 李慶雨 번역 : 譯解編注 黃帝內經素問, 여강출판사, 1권 p317, 318, 333, 334, 2권 p193, 194, 441, 442, 443, 2000.
  8. 許浚 : 原文 對譯 東醫寶鑑 : 여강출판사, p2945, 2946, 2001.
  9. Sona V. Biswas, Rehana iqbal wth Daniel Horton-Szar as series editor, Mosby's Crash Course : Musculoskeletal System, 한우리, p53-54, 2000.
  10. Canalis E., Mechanisms of glucocorticoid Action in Bone : Implications to glucocorticoid-induced Osteoporosis. J. Clin. Endocri. Met. 81, 3441-3447, 1996. https://doi.org/10.1210/jc.81.10.3441
  11. 新谷太, 차봉수역, Steps to Internal Medicine Pathophysiology로 이해하는 내과학내분비 질환 part9, 정담출판사, p93, p130-134, 2002.
  12. Sambrook P, Birmingham J, Kempler S, et al. Corticosteroid effects on proximal femur bone loss, J. Bone Miner Res 5 : 1211-1216, 1990. https://doi.org/10.1002/jbmr.5650051204
  13. Manelli, F. and Giustina, A., Glucocorticoid-induced osteoporosis., Trends Endocrinol. Metab. 11, 79-85. 2000. https://doi.org/10.1016/S1043-2760(00)00234-4
  14. Van Staa, T.P. et al., Use of oral corticosteroids and risk of fracture., J. Bone Miner. Res. 15, p993-1000. 2000. https://doi.org/10.1359/jbmr.2000.15.6.993
  15. Canalis, E. and Giustina, A., Glucocorticoid-induced osteoporosis : summary of a workshop., J. Clin. Endocrinol. Metab. 86, p5681-5685, 2001. https://doi.org/10.1210/jc.86.12.5681
  16. Canalis, E. et al. Perspectives on glucocorticoid-induced osteoporosis., Bone 34, 593-598, 2004. https://doi.org/10.1016/j.bone.2003.11.026
  17. Shaker, J.L. and Lukert, B.P., Osteoporosis associated with excess glucocorticoids., Endocrinol. Metal. Clin. North Am. 34, 341-356, 2005. https://doi.org/10.1016/j.ecl.2005.01.014
  18. Harrison's principles of Internal medicine. 16th edition
  19. Zhang YH, Zhou L, Shi RB, Guo YJ, Dong Y, Studies on chemical constituents in spikes of Schizonepeta tenuifolia., Zhongguo Zhong Yao Za Zhi, 31 : 1247-1249, 2006.
  20. Shin TY, Jeong HJ, Jun SM, Chae HJ, Kim HR, Baek SH, Kim HM, Effect of Schizonepeta tenuifolia extract on mast cell-mediated immediate-type hypersensitivity in rats., Immunopharmacol Immunotoxicol., 21 : 705-715, 1999. https://doi.org/10.3109/08923979909007136
  21. Tohda C, Kakihara Y, Komatsu K, Kuraishi Y., Inhibitory effects of methanol extracts of herbal medicines on substance P-induced itch-scratch responce., Biol Pharm Bull., 23 : 599-601, 2000. https://doi.org/10.1248/bpb.23.599
  22. Park IK, Kim LS, Choi IH, Lee YS, Shin SC, Fumigant activity of plant essential oils and components from Schizonepeta tenuifolia against Lycoriella ingenua(Diptera : Sciardae)., J. Econ Entomol., 99: 1717-1721, 2006. https://doi.org/10.1603/0022-0493-99.5.1717